While these compounds are partially selective for PHD inhibition and may well be suitable for AML treatment, they inhibit other 2OG-dependent oxygenases, including JMJD6 (refs. 7,15), which is required for normal hematopoiesis and HSC maintenance58. Here, JMJD6 is linked to acute myeloid leukemia.